Publications 2011

 1.  Roberts RL, Hollis-Moffatt JE, Gomez-Garcia M, Fransen K, Ponsioen CY, Crusius JBA, Wijmenga C, Martin J, Weersma RK, Merriman TR, Barclay ML, Gearry RB, Alizadeh BZ.
Association of the protein-tyrosine phosphatase nonreceptor type substrate 1 (PTPNS1) gene with inflammatory bowel disease.
Inflammatory Bowel Diseases 2011;17:E19-21.

 2.  Karimi O and Peña AS.
Probiotics in Clinical Practice as Therapeutics against Enteric Disorders. Chapter 15.
In: Book "Probiotic Bacteria and Enteric Infections. Cytoprotection by probiotics". JJ Malago,
JFJG Koninkx and R Marinsek-Logar Editors
Publisher Springer-Science + Business Media B.V. 2011;355-373.

 3.   Ruettger A, Feige J, Slickers P, Schubert E, Morré SA, Pannekoek Y, Herrmann B, de Vries HJC, Ehricht R, Sachse K.
Genotyping of Chlamydia trachomatis strains from culture and clinical samples using an ompA-based DNA microarray assay.
Mol Cel Probes 2011;25:19-27.

 4.  Sanders MS, van Well GThJ, Ouburg S, Lundberg PSJ, van Furth AM, Morré SA.
Single nucleotide polymorphisms in TLR9 are highly associated with susceptibility to bacterial meningitis in children.
Clin Infect Dis 2011;52:475-80.

 5.  Quint KD, Geraets DT, van den Munckhof HAM, de Koning MNC, Smelov V, Melchers WJG, de Vries HJC, Morré SA, Meijer CJM, van Alewijk DCJG , van Doorn LJ, Quint WHV.
Evaluation of a novel Chlamydia trachomatis Microsphere Suspension assay for detection and genotyping of the different serovars in clinical samples.
J Mol Diagn 2011;13:152-159.

 6.  Sombekke MH, Vellinga MM, Uitdehaag BMJ, Barkhof F, Polman CH, Arteta D, Tejedor D, Martinez A, Crusius JBA, Peña AS, Geurts JJG, Vrenken H.
Genetic correlations of brain lesion distribution in Multiple Sclerosis - an exploratory study.
Am J Neuroradiol. 2011;32:695-703.

 7.  Quint KD, Bom RJ; Quint WG, Bruisten SM, van der Loeff MFS, Morré SA, de Vries HJ.
Anal infections with concomitant Chlamydia trachomatis genotypes among men who have sex with men in Amsterdam, the Netherlands.
BMC infectious diseases 2011;11:63-69

 8. Vosslamber S, van der Voort LF, van den Elskamp IJ, Heijmans R, Aubin C, Uitdehaag BMJ, Crusius JBA, van der Pouwkraan TCTM, Comabella M, Montalban X, Hafler DA, De Jager PL, Killestein J, Polman CH, Verweij CL.
Interferon regulatory factor 5 gene variants and pharmacological and clinical outcome of Interferon beta therapy in multiple sclerosis.
Genes Immun. 2011;12(6):466-472; doi:10.1038/gene.2011.18

 9.  Sombekke MH, van der Voort LF, Kragt JJ, Nielsen JM, Guzel H, Visser A, Oudejans CBM, Crusius JBA, Peña AS, Vrenken H, Polman CH, Killestein J.
Relevance of IL7R genotype and mRNA expression in Dutch patients with multiple sclerosis.
Multiple Sclerosis 2011;17(8):922-30. doi:10.1177/1352458511402411

10. Ksiadzyna D and Peña AS.
Abdominal Splenosis.
Rev Esp Enferm Diges  2011;103(8):421-426

11. Peña AS.
Short- and long-term complications after restorative proctocolectomy with ileal pouch-anal anastomosis. (Editorial).
Annals of Gastroenterology 2011;24:161-163

12. Nijmeijer RM, Gadaleta RM, van Mil SWC, van Bodegraven AA, Crusius JBA, Dijkstra G, Hommes DW, de Jong DJ, Stokkers PCF, Verspaget HW, Weersma RK, van der Woude CJ,  Stapelbroek JM, Schipper MEI, Wijmenga C, van Erpecum KJ, Oldenburg B on behalf of the Dutch Initiative on Crohn and Colitis (ICC).
Farnesoid X Receptor (FXR) activation and FXR genetic variation in inflammatory bowel disease.
PLoS ONE 2011;6(8): e23745. doi:10.1371/journal.pone.0023745
Tables Suppl online:   

13.  Díaz-Gallo LM, Espino-Paisan L, Fransen K, Gómez-Garcia M, van Sommeren S, Cardeña C, Rodrigo L, Mendoza JL, Taxonera C, Nieto A, Alcain G, Cueto I, López-Nevot MA, Bottini N, Barclay ML, Crusius JBA, van Bodegraven AA, Wijmenga C, Ponsioen CY, Gearry RB, Roberts RL, Weersma RK, Urcelay E, Merriman TR, Alizadeh BZ, Martin J.
Differential association of two PTPN22 coding variants with Crohn´s disease and ulcerative colitis.
Inflammatory Bowel Diseases 2011;17(11):2287-94

14.  Smelov V, van Moorselaar J, Startsev V, Smelova N, Grigorovich E, Meijer CJLM, Morré SA.
No high-risk human papillomavirus infection in prostate cancer tissues.

Scand J Infect Dis 2011;43:399-400.

15. Peters RPH, Nijsten N, Mutsaers J, Jansen CL, Morré SA, van Leeuwen AP
Screening of oropharynx and anorectum increases prevalence of Chlamydia trachomatis and Neisseria gonorrhoea infection in female STD clinic visitors.
Sex Transm Dis 2011; 38:783-787.

16. Sanders MS, van Well GThJ, Ouburg S, Morré SA, van Furth AM.
Genetic variation of innate immune response genes in invasive pneumococcal and meningococcal disease applied to the pathogenesis of meningitis.
Genes Immun 2011;12(5):321-334

17. Verweij S, Catsburg A, Ouburg S, Lombardi A, Heijmans R, Dutly F, Frei R, Morré SA, Goldenberger D.
Lymphogranuloma venereum variant L2b-specific polymerase chain reaction: insertion used to close an epidemiological gap.
Clin Microbiol Infect 2011;17(11):1727-30.

18. Christerson L, de Vries HJC, Klint M, Herrmann B, Morré SA.
Multilocus Sequence Typing of Urogenital Chlamydia trachomatis from Patients with Different Degrees of Clinical Symptoms.
Sex Transm Dis 2011; 38(6):490-494

19.  Peters RPH, Verweij SP, Nijsten N, Ouburg S, Mutsaers J, Jansen CL, van Leeuwen AP, Morré SA.
Evaluation of sexual history-based screening of anatomic sites for Chlamydia trachomatis and Neisseria gonorrhoeae infection in men having sex with men in routine practice.
BMC Infect Dis. 2011;11:203. (pp 1-7)

20.  Bongaerts M, van de Bovenkamp JHB, Morré SA, Manders MELM and Heddema ER.
Evaluation of the Siemens VERSANT(r) CT/GC DNA 1.0 Assay (kPCR) for detection of Chlamydia trachomatis and Neisseria gonorrhoeae.
Journal of Microbiological Methods 2011; 87(2):139-42.

21.  Bax CJ, Quint KD, Peters RPH, Ouburg S, Oostvogel PM, Mutsaers JAEM, Dörr PJ, Schmidt S, Jansen C, van Leeuwen AP, Quint WGV, Trimbos JB, Meijer CJLM, Morré SA.
Analyses of multiple-site and concurrent Chlamydia trachomatis serovar infections, and serovar tissue tropism for urogenital versus rectal specimens in male and female patients.
Sex Transm Infect. 2011; 87(6):503-7. doi:10.1136/sti.2010.048173

22.  Lal JA, Schulte in den Bäumen T, Morré SA, Brand A.
Public Health and valorization of genome-based technologies: a new model.
J Transl Med 2011;9(1):207. doi:10.1186/1479-5876-9-207